CVS Group Past Earnings Performance
Past criteria checks 2/6
CVS Group has been growing earnings at an average annual rate of 31.3%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 10% per year. CVS Group's return on equity is 10.1%, and it has net margins of 4%.
Key information
31.3%
Earnings growth rate
31.0%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 10.0% |
| Return on equity | 10.1% |
| Net Margin | 4.0% |
| Next Earnings Update | 27 Feb 2025 |
Recent past performance updates
Recent updates
CVS Group (LON:CVSG) Has A Somewhat Strained Balance Sheet
Dec 04
CVS Group plc's (LON:CVSG) Price In Tune With Earnings
Oct 16Should You Think About Buying CVS Group plc (LON:CVSG) Now?
Sep 10CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
Jun 05CVS Group (LON:CVSG) Has A Pretty Healthy Balance Sheet
Mar 28CVS Group (LON:CVSG) Is Looking To Continue Growing Its Returns On Capital
Feb 29Getting In Cheap On CVS Group plc (LON:CVSG) Is Unlikely
Feb 09Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
Dec 11Most Shareholders Will Probably Agree With CVS Group plc's (LON:CVSG) CEO Compensation
Nov 23Is CVS Group (LON:CVSG) A Risky Investment?
Nov 15CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 89% Above Its Share Price
Oct 27Here's Why CVS Group (LON:CVSG) Has Caught The Eye Of Investors
Sep 23CVS Group's (LON:CVSG) Returns On Capital Are Heading Higher
Sep 08We Think CVS Group (LON:CVSG) Can Stay On Top Of Its Debt
Jun 28Should You Investigate CVS Group plc (LON:CVSG) At UK£20.72?
May 25A Look At The Fair Value Of CVS Group plc (LON:CVSG)
May 12Should You Be Adding CVS Group (LON:CVSG) To Your Watchlist Today?
Apr 15A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Feb 01Here's Why We Think CVS Group (LON:CVSG) Might Deserve Your Attention Today
Jan 05Returns At CVS Group (LON:CVSG) Are On The Way Up
Nov 30CVS Group plc's (LON:CVSG) CEO Looks Like They Deserve Their Pay Packet
Nov 17CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 41% Above Its Share Price
Oct 26Does CVS Group (LON:CVSG) Have A Healthy Balance Sheet?
Sep 29Is Now The Time To Put CVS Group (LON:CVSG) On Your Watchlist?
Sep 17At UK£16.41, Is It Time To Put CVS Group plc (LON:CVSG) On Your Watch List?
Sep 02CVS Group's (LON:CVSG) Returns On Capital Are Heading Higher
Aug 04Here's Why We Think CVS Group (LON:CVSG) Is Well Worth Watching
Jun 14Should You Investigate CVS Group plc (LON:CVSG) At UK£17.94?
Jun 01CVS Group (LON:CVSG) Is Looking To Continue Growing Its Returns On Capital
May 05Is CVS Group (LON:CVSG) A Risky Investment?
Apr 23Is There An Opportunity With CVS Group plc's (LON:CVSG) 37% Undervaluation?
Apr 09When Should You Buy CVS Group plc (LON:CVSG)?
Feb 19A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Nov 23Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
Oct 25Here's Why We Think CVS Group (LON:CVSG) Is Well Worth Watching
Oct 12We Think CVS Group (LON:CVSG) Can Manage Its Debt With Ease
Sep 26CVS Group (LON:CVSG) Has Some Way To Go To Become A Multi-Bagger
Aug 27A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Aug 05Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
Jun 16Return Trends At CVS Group (LON:CVSG) Aren't Appealing
May 16Estimating The Fair Value Of CVS Group plc (LON:CVSG)
May 01We Think CVS Group (LON:CVSG) Can Stay On Top Of Its Debt
Apr 16Revenue & Expenses Breakdown
How CVS Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 647 | 26 | 202 | 0 |
| 31 Dec 23 | 642 | 35 | 195 | 0 |
| 30 Sep 23 | 625 | 39 | 186 | 0 |
| 30 Jun 23 | 589 | 48 | 167 | 0 |
| 31 Mar 23 | 593 | 36 | 179 | 0 |
| 31 Dec 22 | 577 | 29 | 181 | 0 |
| 30 Sep 22 | 566 | 28 | 178 | 0 |
| 30 Jun 22 | 554 | 26 | 174 | 0 |
| 31 Mar 22 | 546 | 26 | 167 | 0 |
| 31 Dec 21 | 538 | 26 | 159 | 0 |
| 30 Sep 21 | 524 | 22 | 159 | 0 |
| 30 Jun 21 | 510 | 19 | 158 | 0 |
| 31 Mar 21 | 480 | 15 | 152 | 0 |
| 31 Dec 20 | 449 | 11 | 145 | 0 |
| 30 Sep 20 | 438 | 9 | 137 | 0 |
| 30 Jun 20 | 428 | 6 | 128 | 0 |
| 31 Mar 20 | 432 | 9 | 126 | 0 |
| 31 Dec 19 | 436 | 13 | 123 | 0 |
| 30 Sep 19 | 421 | 11 | 127 | 0 |
| 30 Jun 19 | 407 | 8 | 131 | 0 |
| 31 Mar 19 | 386 | 7 | 130 | 0 |
| 31 Dec 18 | 365 | 7 | 129 | 0 |
| 30 Sep 18 | 346 | 9 | 122 | 0 |
| 30 Jun 18 | 327 | 11 | 116 | 0 |
| 31 Mar 18 | 314 | 10 | 110 | 0 |
| 31 Dec 17 | 300 | 10 | 105 | 0 |
| 30 Sep 17 | 286 | 11 | 98 | 0 |
| 30 Jun 17 | 272 | 12 | 91 | 0 |
| 31 Mar 17 | 259 | 11 | 92 | 0 |
| 31 Dec 16 | 247 | 10 | 92 | 0 |
| 30 Sep 16 | 232 | 8 | 86 | 0 |
| 30 Jun 16 | 218 | 7 | 80 | 0 |
| 31 Mar 16 | 202 | 7 | 74 | 0 |
| 31 Dec 15 | 186 | 6 | 68 | 0 |
| 30 Sep 15 | 177 | 6 | 65 | 0 |
| 30 Jun 15 | 167 | 7 | 61 | 0 |
| 31 Mar 15 | 162 | 7 | 63 | 0 |
| 31 Dec 14 | 156 | 6 | 65 | 0 |
| 30 Sep 14 | 149 | 6 | 58 | 0 |
| 30 Jun 14 | 143 | 5 | 50 | 0 |
| 31 Mar 14 | 137 | 5 | 40 | 0 |
| 31 Dec 13 | 131 | 5 | 30 | 0 |
Quality Earnings: CVSG has high quality earnings.
Growing Profit Margin: CVSG's current net profit margins (4%) are lower than last year (8.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CVSG's earnings have grown significantly by 31.3% per year over the past 5 years.
Accelerating Growth: CVSG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CVSG had negative earnings growth (-45.5%) over the past year, making it difficult to compare to the Healthcare industry average (15.5%).
Return on Equity
High ROE: CVSG's Return on Equity (10.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 00:25 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CVS Group plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Bayliss | Berenberg |
| Robert Chantry | Berenberg |
| Conall MacCoille | Davy |